Targeting infections within the gastrointestinal tract

Hannah Batchelor, Barbara Conway

Research output: Chapter in Book/Report/Conference proceedingChapter

4 Citations (Scopus)

Abstract

Pharmaceuticals remain the least invasive and most cost-effective means of patient treatment, and represent a substantially important factor in the potential reductionof long-term, overall healthcare costs. The pharmaceutical industry continues to evolve within a transitional environment as most of the elements affecting its core business have changed. Drug companies are confronting the consequences of managed care, increased pricing pressures, generic competition, and overall margin shrinkage. In response, they are vigorously seeking new ways to increase profitability, differentiate their products, and add depth and diversity to their product lines. One of these alternatives is to exploit improvements upon the method of drug delivery.

Original languageEnglish
Title of host publicationAdvanced Drug Formulation Design to Optimize Therapeutic Outcomes
EditorsRobert O. Williams III, David R. Taft, Jason T. McConville
PublisherCRC Press
Chapter7
Pages217-244
Number of pages28
ISBN (Electronic)9781420043884
ISBN (Print)9781420043877
Publication statusPublished - 25 Sep 2007
Externally publishedYes

Publication series

NameDrugs and the Pharmaceutical Series

Fingerprint

Gastrointestinal Tract
Infection
Pharmaceutical Preparations
Costs and Cost Analysis
Drug Industry
Managed Care Programs
Health Care Costs
Pressure
Therapeutics

Cite this

Batchelor, H., & Conway, B. (2007). Targeting infections within the gastrointestinal tract. In R. O. Williams III, D. R. Taft, & J. T. McConville (Eds.), Advanced Drug Formulation Design to Optimize Therapeutic Outcomes (pp. 217-244). (Drugs and the Pharmaceutical Series). CRC Press.
Batchelor, Hannah ; Conway, Barbara. / Targeting infections within the gastrointestinal tract. Advanced Drug Formulation Design to Optimize Therapeutic Outcomes. editor / Robert O. Williams III ; David R. Taft ; Jason T. McConville. CRC Press, 2007. pp. 217-244 (Drugs and the Pharmaceutical Series).
@inbook{3ae58b42ab9948c58196136d6818f0bf,
title = "Targeting infections within the gastrointestinal tract",
abstract = "Pharmaceuticals remain the least invasive and most cost-effective means of patient treatment, and represent a substantially important factor in the potential reductionof long-term, overall healthcare costs. The pharmaceutical industry continues to evolve within a transitional environment as most of the elements affecting its core business have changed. Drug companies are confronting the consequences of managed care, increased pricing pressures, generic competition, and overall margin shrinkage. In response, they are vigorously seeking new ways to increase profitability, differentiate their products, and add depth and diversity to their product lines. One of these alternatives is to exploit improvements upon the method of drug delivery.",
author = "Hannah Batchelor and Barbara Conway",
year = "2007",
month = "9",
day = "25",
language = "English",
isbn = "9781420043877",
series = "Drugs and the Pharmaceutical Series",
publisher = "CRC Press",
pages = "217--244",
editor = "{Williams III}, {Robert O.} and Taft, {David R.} and McConville, {Jason T.}",
booktitle = "Advanced Drug Formulation Design to Optimize Therapeutic Outcomes",

}

Batchelor, H & Conway, B 2007, Targeting infections within the gastrointestinal tract. in RO Williams III, DR Taft & JT McConville (eds), Advanced Drug Formulation Design to Optimize Therapeutic Outcomes. Drugs and the Pharmaceutical Series, CRC Press, pp. 217-244.

Targeting infections within the gastrointestinal tract. / Batchelor, Hannah; Conway, Barbara.

Advanced Drug Formulation Design to Optimize Therapeutic Outcomes. ed. / Robert O. Williams III; David R. Taft; Jason T. McConville. CRC Press, 2007. p. 217-244 (Drugs and the Pharmaceutical Series).

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Targeting infections within the gastrointestinal tract

AU - Batchelor, Hannah

AU - Conway, Barbara

PY - 2007/9/25

Y1 - 2007/9/25

N2 - Pharmaceuticals remain the least invasive and most cost-effective means of patient treatment, and represent a substantially important factor in the potential reductionof long-term, overall healthcare costs. The pharmaceutical industry continues to evolve within a transitional environment as most of the elements affecting its core business have changed. Drug companies are confronting the consequences of managed care, increased pricing pressures, generic competition, and overall margin shrinkage. In response, they are vigorously seeking new ways to increase profitability, differentiate their products, and add depth and diversity to their product lines. One of these alternatives is to exploit improvements upon the method of drug delivery.

AB - Pharmaceuticals remain the least invasive and most cost-effective means of patient treatment, and represent a substantially important factor in the potential reductionof long-term, overall healthcare costs. The pharmaceutical industry continues to evolve within a transitional environment as most of the elements affecting its core business have changed. Drug companies are confronting the consequences of managed care, increased pricing pressures, generic competition, and overall margin shrinkage. In response, they are vigorously seeking new ways to increase profitability, differentiate their products, and add depth and diversity to their product lines. One of these alternatives is to exploit improvements upon the method of drug delivery.

UR - http://www.scopus.com/inward/record.url?scp=82255175760&partnerID=8YFLogxK

UR - https://www.crcpress.com/Advanced-Drug-Formulation-Design-to-Optimize-Therapeutic-Outcomes/Williams-Taft-McConville/p/book/9781420043877

M3 - Chapter

SN - 9781420043877

T3 - Drugs and the Pharmaceutical Series

SP - 217

EP - 244

BT - Advanced Drug Formulation Design to Optimize Therapeutic Outcomes

A2 - Williams III, Robert O.

A2 - Taft, David R.

A2 - McConville, Jason T.

PB - CRC Press

ER -

Batchelor H, Conway B. Targeting infections within the gastrointestinal tract. In Williams III RO, Taft DR, McConville JT, editors, Advanced Drug Formulation Design to Optimize Therapeutic Outcomes. CRC Press. 2007. p. 217-244. (Drugs and the Pharmaceutical Series).